|  |  |  | | | | | TE-RegenMed-StemCell feed | | | | | | | | | | | | | | | | | | Directors of the California stem cell agency are planning at least three public meetings prior to making their decision on cardiologist Frank Litvack or bond financier Jonathan Thomas to replace outgoing chairman Robert Klein at the end of June.
The public will have a chance to weigh in with comments at all of the meetings. Two sessions have telephonic locations throughout the state, including | | | | | | | | | | | | | | | | | | | | | | | | The $3 billion California stem cell agency made the papers this weekend in Los Angeles and San Francisco.
One story dealt with research funded by CIRM, the other with selection of its next chairman.
The story by freelance writer Amber Dance in the Los Angeles Times was the sort of coverage that CIRM needs more of if it is to win approval of the possible, new $5 billion bond measure touted by | | | | | | | | | | | | | | | | | | | | | | | | The International Society for Stem Cell Research announced last week that it is making its first ever public service award to Robert Klein, the outgoing chairman of the $3 billion California stem cell agency.
In a news release, the scientific group cited Klein "for his outstanding contribution of public service to the field of stem cell research and regenerative medicine."
The ISSCR said,
" | | | | | | | | | | | | | | | | | | | | | | | | The Institute of Medicine study of the $3 billion California stem cell agency begins in July but the full IOM committee is not expected to be appointed until next fall.
Responding to an inquiry from the California Stem Cell Report, Adrienne Stith Butler, study director for the $700,000 CIRM-financed project, said that the IOM will make information about the process available on the Internet in | | | | | | | | | |  | |  | |  |
No comments:
Post a Comment